Literature DB >> 21397652

Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression.

E K Michaelis1, X Wang, R Pal, X Bao, K N Hascup, Y Wang, W-T Wang, D Hui, A Agbas, I-Y Choi, A Belousov, G A Gerhardt.   

Abstract

Glutamate dehydrogenase 1 (GLUD1) is a mitochondrial enzyme expressed in all tissues, including brain. Although this enzyme is expressed in glutamatergic pathways, its function as a regulator of glutamate neurotransmitter levels is still not well defined. In order to gain an understanding of the role of GLUD1 in the control of glutamate levels and synaptic release in mammalian brain, we generated transgenic (Tg) mice that over-express this enzyme in neurons of the central nervous system. The Tg mice have increased activity of GLUD, as well as elevated levels and increased synaptic and depolarization-induced release of glutamate. These mice suffer age-associated losses of dendritic spines, nerve terminals, and neurons. The neuronal losses and dendrite structural changes occur in select regions of the brain. At the transcriptional level in the hippocampus, cells respond by increasing the expression of genes related to neurite growth and synapse formation, indications of adaptive or compensatory responses to the effects of increases in the release and action of glutamate at synapses. Because these Tg mice live to a relatively old age they are a good model of the effects of a "hyperglutamatergic" state on the aging process in the nervous system. The mice are also useful in defining the molecular pathways affected by the over-activation of GLUD in glutamatergic neurons of the brain and spinal cord.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397652      PMCID: PMC3152645          DOI: 10.1016/j.neuint.2011.03.003

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  41 in total

1.  Late memory-related genes in the hippocampus revealed by RNA fingerprinting.

Authors:  S Cavallaro; N Meiri; C L Yi; S Musco; W Ma; J Goldberg; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Characterization of glutamate dehydrogenase isoproteins purified from the cerebellum of normal subjects and patients with degenerative neurological disorders, and from human neoplastic cell lines.

Authors:  M M Hussain; V I Zannis; A Plaitakis
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

3.  Neocortical cell counts in normal human adult aging.

Authors:  R D Terry; R DeTeresa; L A Hansen
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

4.  Neuronal damage and MAP2 changes induced by the glutamate transport inhibitor dihydrokainate and by kainate in rat hippocampus in vivo.

Authors:  C Arias; I Arrieta; L Massieu; R Tapia
Journal:  Exp Brain Res       Date:  1997-10       Impact factor: 1.972

5.  From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development.

Authors:  Toshiko R Matsugami; Kentaro Tanemura; Michihiro Mieda; Reiko Nakatomi; Keiko Yamada; Takashi Kondo; Masaharu Ogawa; Kunihiko Obata; Masahiko Watanabe; Tsutomu Hashikawa; Kohichi Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

6.  Quantitative synaptic alterations in the human neocortex during normal aging.

Authors:  E Masliah; M Mallory; L Hansen; R DeTeresa; R D Terry
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

7.  Aging of membrane transport mechanisms in the central nervous system--high affinity glutamic acid transport in rat cortical synaptosomes.

Authors:  D D Wheeler
Journal:  Exp Gerontol       Date:  1980       Impact factor: 4.032

8.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

9.  Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Yannan Ouyang; Vered Gazit; John R Cirrito; Laura A Jansen; Kevin C Ess; Kelvin A Yamada; David F Wozniak; David M Holtzman; David H Gutmann; Michael Wong
Journal:  Neurobiol Dis       Date:  2007-07-21       Impact factor: 5.996

10.  Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.

Authors:  Andreas Plaitakis; Helen Latsoudis; Konstantinos Kanavouras; Beate Ritz; Jeff M Bronstein; Irene Skoula; Vasileios Mastorodemos; Spyridon Papapetropoulos; Nikolas Borompokas; Ioannis Zaganas; Georgia Xiromerisiou; George M Hadjigeorgiou; Cleanthe Spanaki
Journal:  Eur J Hum Genet       Date:  2009-10-14       Impact factor: 4.246

View more
  13 in total

Review 1.  Electrochemical techniques for subsecond neurotransmitter detection in live rodents.

Authors:  Kevin N Hascup; Erin R Hascup
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

2.  Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice.

Authors:  In-Young Choi; Phil Lee; Wen-Tung Wang; Dongwei Hui; Xinkun Wang; William M Brooks; Elias K Michaelis
Journal:  Neurochem Res       Date:  2014-01-21       Impact factor: 3.996

3.  Glutaminase activity in GLS1 Het mouse brain compared to putative pharmacological inhibition by ebselen using ex vivo MRS.

Authors:  Lauren Kosten; Golam M I Chowdhury; Susana Mingote; Steven Staelens; Douglas L Rothman; Kevin L Behar; Stephen Rayport
Journal:  Neurochem Int       Date:  2019-07-19       Impact factor: 3.921

4.  Ischemic tolerance in an in vivo model of glutamate preconditioning.

Authors:  Yomna Badawi; Ranu Pal; Dongwei Hui; Elias K Michaelis; Honglian Shi
Journal:  J Neurosci Res       Date:  2014-11-25       Impact factor: 4.164

5.  Effective Mechanism for Synthesis of Neurotransmitter Glutamate and its Loading into Synaptic Vesicles.

Authors:  Kouji Takeda; Tetsufumi Ueda
Journal:  Neurochem Res       Date:  2016-08-26       Impact factor: 3.996

6.  Effects of Ethanol Exposure on the Neurochemical Profile of a Transgenic Mouse Model with Enhanced Glutamate Release Using In Vivo 1H MRS.

Authors:  Wen-Tung Wang; Phil Lee; Dongwei Hui; Elias K Michaelis; In-Young Choi
Journal:  Neurochem Res       Date:  2018-10-17       Impact factor: 3.996

7.  Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction.

Authors:  Sharon S Lander; Usman Khan; Nicole Lewandowski; Darpan Chakraborty; Frank A Provenzano; Susana Mingote; Sergiy Chornyy; Francesca Frigerio; Pierre Maechler; Hanoch Kaphzan; Scott A Small; Stephen Rayport; Inna Gaisler-Salomon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

8.  Analysis of Brain Protein Stability Changes in Mouse Models of Normal Aging and α-Synucleinopathy Reveals Age- and Disease-Related Differences.

Authors:  Renze Ma; Julia H R Johnson; Yun Tang; Michael C Fitzgerald
Journal:  J Proteome Res       Date:  2021-10-04       Impact factor: 5.370

9.  Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate Neurotransmission.

Authors:  Holly M Brothers; Isabelle Bardou; Sarah C Hopp; Yannick Marchalant; Roxanne M Kaercher; Sarah M Turner; Mollie R Mitchem; Kristina Kigerl; Gary L Wenk
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-03-28

10.  Aging and chronic administration of serotonin-selective reuptake inhibitor citalopram upregulate Sirt4 gene expression in the preoptic area of male mice.

Authors:  Dutt Way Wong; Tomoko Soga; Ishwar S Parhar
Journal:  Front Genet       Date:  2015-09-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.